Abstract Background: Despite advances in immunosuppressive therapies, lupus nephritis (LN) continues to be a major contributor to morbidity and mortality. The scarcity of reliable biomarkers for predicting renal outcomes further complicates clinical management. While Cordyceps is recognized for its immunomodulatory properties as a medicinal fungus, its therapeutic potential in LN remains underexplored.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile